Regulatory T cells: Magic bullets for immunotherapy?

Archivum Immunologiae et Therapiae Experimentalis

Volumn 54, Issue 1, 2006, Pages 33-43

  Frey, Oliver ^a,b   Bräuer, Rolf ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Autoimmune disease; Immunoregulation; Infection; Inflammation; Regulatory T cell; T cell subset

Indexed keywords

ANTIGEN; BASILIXIMAB; CELL MARKER; COLLAGEN TYPE 2; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; MONOCLONAL ANTIBODY CD28; MONOCLONAL ANTIBODY CD3; MYELIN BASIC PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ANTIBODY; INTERLEUKIN 2 RECEPTOR;

ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CELL ACTIVITY; CELL FUNCTION; CELLULAR DISTRIBUTION; CHRONIC INFLAMMATION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INFLAMMATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE SUBPOPULATION; VACCINATION; ADOPTIVE IMMUNOTHERAPY; ANIMAL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; NEOPLASM;

ANIMALS; AUTOIMMUNE DISEASES; CYTOKINES; HUMANS; IMMUNOTHERAPY; IMMUNOTHERAPY, ADOPTIVE; LYMPHOCYTE ACTIVATION; NEOPLASMS; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES, REGULATORY;

EID: 33745488590     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-006-0008-0     Document Type: Review

References (114)

1. Alegre M. L., Frauwirth K. A. and Thompson C. B. (2001): T-cell regulation by CD28 and CTLA-4. Nat. Rev. Immunol., 1, 220-228.
2. Almeida A. R., Legrand N., Papiernik M. and Freitas A. A. (2002): Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J. Immunol., 169, 4850-4860.
3. Annacker O., Pimenta-Araujo R., Burlen-Defranoux O., Barbosa T. C., Cumano A. and Bandeira A. (2001): CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J. Immunol., 166, 3008-3018.
4. Annunziato F., Cosmi L., Liotta F., Lazzeri E., Manetti R., Vanini V., Romagnani P., Maggi E. and Romagnani S. (2002): Phenotype, localization, and mechanism of suppression of CD4+ CD25+ human thymocytes. J. Exp. Med., 196, 379-387.
5. Apostolou I., Sarukhan A., Klein L. and von Boehmer H. (2002): Origin of regulatory T cells with known specificity for antigen. Nat. Immunol., 3, 756-763.
6. Apostolou I. and von Boehmer H. (2004): In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med., 199, 1401-1408.
7. Asano M., Toda M., Sakaguchi N. and Sakaguchi S. (1996): Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med., 184, 387-396.
8. Asseman C., Read S. and Powrie F. (2003): Colitogenic Th1 cells are present in the antigen-experienced T cell pool in normal mice: control by CD4+ regulatory T cells and IL-10. J. Immunol., 171, 971-978.
9. Baecher-Allan C., Brown J. A., Freeman G. J. and Hafler D. A. (2001): CD4+CD25high regulatory cells in human peripheral blood. J. Immunol., 167, 1245-1253.
10. Banz A., Peixoto A., Pontoux C., Cordier C., Rocha B. and Papiernik M. (2003): A unique subpopulation of CD4+ regulatory T cells controls wasting disease, IL-10 secretion and T cell homeostasis. Eur. J. Immunol., 33, 2419-2428.
11. Barthlott T., Kassiotis G. and Stockinger B. (2003): T cell regulation as a side effect of homeostasis and competition. J. Exp. Med., 197, 451-460.
12. Belghith M., Bluestone J. A., Barriot S., Megret J., Bach J. F. and Chatenoud L. (2003): TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat. Med., 9, 1202-1208.
13. Belkaid Y., Piccirillo C. A., Mendez S., Shevach E. M. and Sacks D. L. (2002): CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature, 420, 502-507.
14. Bennett C. L., Christie J., Ramsdell F., Brunkow M. E., Ferguson P. J., Whitesell L., Kelly T. E., Saulsbury F. T., Chance P. F. and Ochs H. D. (2001): The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet., 27, 20-21.
15. Bluestone J. A. and Abbas A. K. (2003): Natural versus adaptive regulatory T cells. Nat. Rev. Immunol., 3, 253-257.
16. Bluestone J. A. and Tang Q. (2004): Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells. Proc. Natl. Acad. Sci. USA, 101 (suppl. 2), 14622-14626.
17. Bystry R. S., Aluvihare V., Welch K. A., Kallikourdis M. and Betz A. G. (2001): B cells and professional APCs recruit regulatory T cells via CCL4. Nat. Immunol., 2, 1126-1132.
18. Cao D., Vollenhoven R., Klareskog L., Trollmo C. and Malmstrom V. (2004): CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res. Ther., 6, R335-346.
19. Cederbom L., Hall H. and Ivars F. (2000): CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol., 30, 1538-1543.
20. Chai J. G., Tsang J. Y., Lechler R., Simpson E., Dyson J. and Scott D. (2002): CD4+CD25+ T cells as immunoregulatory T cells in vitro. Eur. J. Immunol., 32, 2365-2375.
21. Chen W., Jin W., Hardegen N., Lei K.-j., Li L., Marinos N., McGrady G. and Wahl S. M. (2003): Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med., 198, 1875-1886.
22. Chen W., Jin W. and Wahl S. M. (1998): Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells. J. Exp. Med., 188, 1849-1857.
23. Cobbold S. P., Castejon R., Adams E., Zelenika D., Graca L., Humm S. and Waldmann H. (2004): Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J. Immunol., 172, 6003-6010.
24. Curiel T. J., Coukos G., Zou L., Alvarez X., Cheng P., Mottram P., Evdemon-Hogan M., Conejo-Garcia J. R., Zhang L., Burow M., Zhu Y., Wei S., Kryczek I., Daniel B., Gordon A., Myers L., Lackner A., Disis M. L., Knutson K. L., Chen L. and Zou W. (2004): Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med., 10, 942-949.
25. de Kleer I. M., Wedderburn L. R., Taams L. S., Patel A., Varsani H., Klein M., de Jager W., Pugayung G., Giannoni F., Rijkers G., Albani S., Kuis W. and Prakken B. (2004): CD4+CD25(bright) regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J. Immunol., 172, 6435-6443.
26. de la Rosa M., Rutz S., Dorninger H. and Scheffold A. (2004): Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur. J. Immunol., 34, 2480-2488.
27. Dieckmann D., Bruett C. H., Ploettner H., Lutz M. B. and Schuler G. (2002): Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]. J. Exp. Med., 196, 247-253.
28. Ehrenstein M. R., Evans J. G., Singh A., Moore S., Warnes G., Isenberg D. A. and Mauri C. (2004): Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J. Exp. Med., 200, 277-285.
29. Ermann J., Szanya V., Ford G. S., Paragas V., Fathman C. G. and Lejon K. (2001): CD4+CD25+ T cells facilitate the induction of T cell anergy. J. Immunol., 167, 4271-4275.
30. Fallarino F., Grohmann U., Hwang K. W., Orabona C., Vacca C., Bianchi R., Belladonna M. L., Fioretti M. C., Alegre M. L. and Puccetti P. (2003): Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol., 4, 1206-1212.
31. Fantini M. C., Becker C., Monteleone G., Pallone F., Galle P. R. and Neurath M. F. (2004): Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol., 172, 5149-5153.
32. Fisson S., Darrasse-Jeze G., Litvinova E., Septier F., Klatzmann D., Liblau R. and Salomon B. L. (2003): Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J. Exp. Med., 198, 737-746.
33. Fontenot J. D., Gavin M. A. and Rudensky A. Y. (2003): Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol., 4, 330-336.
34. Foussat A., Cottrez F., Brun V., Fournier N., Breittmayer J.-P. and Groux H. (2003): A comparative study between T regulatory type 1 and CD4+CD25+ T cells in the control of inflammation. J. Immunol., 171, 5018-5026.
35. Frey O., Petrow P. K., Gajda M., Siegmund K., Huehn J., Scheffold A., Hamann A., Radbruch A. and Brauer R. (2005): The role of regulatory T cells antigen-induced arthritis: Aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells. Arthritis Res. Ther., 7, R291-R301.
36. Furtado G. C., Curotto de Lafaille M. A., Kutchukhidze N. and Lafaille J. J. (2002): Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J. Exp. Med., 196, 851-857.
37. Gershon R. and Kondo K. (1971): Infectious immunological tolerance. Immunology, 21, 903-914.
38. Golgher D., Jones E., Powrie F., Elliott T. and Gallimore A. (2002): Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens. Eur. J. Immunol., 32, 3267-3275.
39. Graca L., Cobbold S. P. and Waldmann H. (2002): Identification of regulatory T cells in tolerated allografts. J. Exp. Med., 195, 1641-1646.
40. Green E. A., Gorelik L., McGregor C. M., Tran E. H. and Flavell R. A. (2003): CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proc. Natl. Acad. Sci. USA, 100, 10878-10883.
41. Herman A. E., Freeman G. J., Mathis D. and Benoist C. (2004): CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J. Exp. Med., 199, 1479-1489.
42. Hoffmann P., Eder R., Kunz-Schughart L. A., Andreesen R. and Edinger M. (2004): Large-scale in vitro expansion of polyclonal human CD4+CD25high regulatory T cells. Blood, 104, 895-903.
43. Hori S., Nomura T. and Sakaguchi S. (2003): Control of regulatory T cell development by the transcription factor Foxp3. Science, 299, 1057-1061.
44. Hsieh C. S., Liang Y., Tyznik A. J., Self S. G., Liggitt D. and Rudensky A. Y. (2004): Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity, 21, 267-277.
45. Huehn J., Siegmund K., Lehmann J., Siewert C., Haubold U., Feuerer M., Debes G., Lauber J., Frey O., Przybylski G., de la Rosa M., Schmidt C., Brauer R., Buer J., Scheffold A. and Hamann A. (2004): Developmental stage, phenotype and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J. Exp. Med., 199, 303-313.
46. Itoh M., Takahashi T., Sakaguchi N., Kuniyasu Y., Shimizu J., Otsuka F. and Sakaguchi S. (1999): Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol., 162, 5317-5326.
47. Jones E., Dahm-Vicker M., Simon A. K., Green A., Powrie F., Cerundolo V. and Gallimore A. (2002): Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice. Cancer Immun., 2, 1.
48. Jonuleit H., Schmitt E., Kakirman H., Stassen M., Knop J. and Enk A. H. (2002): Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J. Exp. Med., 196, 255-260.
49. Jonuleit H., Schmitt E., Stassen M., Tuettenberg A., Knop J. and Enk A. H. (2001): Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med., 193, 1285-1294.
50. Jordan M. S., Boesteanu A., Reed A. J., Petrone A. L., Holenbeck A. E., Lerman M. A., Naji A. and Caton A. J. (2001): Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol., 2, 301-306.
51. Karim M., Kingsley C. I., Bushell A. R., Sawitzki B. S. and Wood K. J. (2004): Alloantigen-induced CD25+CD4+ regulatory T cells can develop in vivo from CD25-CD4+ precursors in a thymus-independent process. J. Immunol., 172, 923-928.
52. Kawahata K., Misaki Y., Yamauchi M., Tsunekawa S., Setoguchi K., Miyazaki J. and Yamamoto K. (2002): Generation of CD4(+)CD25(+) regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression. J. Immunol., 168, 4399-4405.
53. Khattri R., Cox T., Yasayko S. A. and Ramsdell F. (2003): An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol., 4, 337-342.
54. King C., Ilic A, Koelsch K. and Sarvetnick N. (2004): Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell, 117, 265-277.
55. Kingsley C. I., Karim M., Bushell A. R. and Wood K. J. (2002): CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol., 168, 1080-1086.
56. Klein L., Khazaie K. and von Boehmer H. (2003): In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. USA, 100, 8886-8891.
57. Kuniyasu Y., Takahashi T., Itoh M., Shimizu J., Toda G. and Sakaguchi S. (2000): Naturally anergic and suppressive CD25+CD4+ T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int. Immunol., 12, 1145-1155.
58. Lee M. K. 4th, Moore D. J., Jarrett B. P., Lian M. M., Deng S., Huang X., Markmann J. W., Chiaccio M., Barker C. F., Caton A. J. and Markmann J. F. (2004): Promotion of allograft survival by CD4+CD25+ regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. J. Immunol., 172, 6539-6544.
59. Lehmann J., Huehn J., de la Rosa M., Maszyna F., Kretschmer U., Krenn V., Brunner M., Scheffold A. and Hamann A. (2002): Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25-regulatory T cells. Proc. Natl. Acad. Sci. USA, 99, 13031-13036.
60. Levings M. K., Sangregorio R. and Roncarolo M. G. (2001): Human CD25+CD4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med., 193, 1295-1302.
61. Lin C. H. and Hunig T. (2003): Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist. Eur. J. Immunol., 33, 626-638.
62. Liu H., Hu B., Xu D. and Liew F. Y. (2003): CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-beta, and CTLA4. J. Immunol., 171, 5012-5017.
63. Liyanage U. K., Moore T. T., Joo H. G., Tanaka Y., Herrmann V., Doherty G., Drebin J. A., Strasberg S. M., Eberlein T. J., Goedegebuure P. S. and Linehan D. C. (2002): Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J. Immunol., 169, 2756-2761.
64. Mahnke K., Qian Y., Knop J. and Enk A. H. (2003): Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells. Blood, 101, 4862-4869.
65. Maloy K. J., Salaun L., Cahill R., Dougan G., Saunders N. J. and Powrie F. (2003): CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med., 197, 111-119.
66. Martin B., Banz A, Bienvenu B., Cordier C., Dautigny N., Becourt C. and Lucas B. (2004): Suppression of CD4+ T lymphocyte effector functions by CD4+CD25+ cells in vivo. J. Immunol., 172, 3391-3398.
67. McHugh R. S., Whitters M. J., Piccirillo C. A., Young D. A, Shevach E. M., Collins M. and Byrne M. C. (2002): CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid- induced TNF receptor. Immunity, 16, 311-323.
68. Misra N., Bayry J., Lacroix-Desmazes S., Kazatchkine M. D. and Kaveri S. V. (2004): Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J. Immunol., 172, 4676-4680.
69. Mittrucker H. W. and Kaufmann S. H. (2004): Mini-review: Regulatory T cells and infection: suppression revisited. Eur. J. Immunol., 34, 306-312.
70. Morgan M. E., Sutmuller R. P., Witteveen H. J., van Duivenvoorde L. M., Zanelli E., Melief C. J., Snijders A., Offringa R., de Vries R. R. and Toes R. E. (2003): CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum., 48, 1452-1460.
71. Mottet C., Uhlig H. H. and Powrie F. (2003): Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J. Immunol., 170, 3939-3943.
72. Nakamura K., Kitani A., Fuss I., Pedersen A., Harada N., Nawata H. and Strober W. (2004): TGF-beta1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J. Immunol., 172, 834-842.
73. Nakamura K., Kitani A. and Strober W. (2001): Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med., 194, 629-644.
74. Onizuka S., Tawara I., Shimizu J., Sakaguchi S., Fujita T. and Nakayama E. (1999): Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res., 59, 3128-3133.
75. Pasare C. and Medzhitov R. (2003): Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science, 299, 1033-1036.
76. Peng Y., Laouar Y., Li M. O., Green E. A. and Flavell R. A. (2004): TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. Proc. Natl. Acad. Sci. USA, 101, 4572-4577.
77. Piccirillo C. A., Letterio J. J., Thornton A. M., McHugh R. S., Mamura M., Mizuhara H. and Shevach E. M. (2002): CD4+CD25+ regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J. Exp. Med., 196, 237-246.
78. Piccirillo C. A. and Shevach E. M. (2001): Cutting edge: Control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J. Immunol., 167, 1137-1140.
79. Putheti P., Pettersson A., Soderstrom M., Link H. and Huang Y. M. (2004): Circulating CD4+CD25+ T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs. J. Clin. Immunol., 24, 155-161.
80. Read S., Malmstrom V. and Powrie F. (2000): Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med., 192, 295-302.
81. Sakaguchi S. (2004): Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol., 22, 531-562.
82. Sakaguchi S., Sakaguchi N., Asano M., Itoh M. and Toda M. (1995): Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol., 155, 1151-1164.
83. Sarween N., Chodos A., Raykundalia C., Khan M., Abbas A.K. and Walker L. S. (2004): CD4+CD25+ cells controlling a pathogenic CD4 response inhibit cytokine differentiation, CXCR-3 expression, and tissue invasion. J. Immunol., 173, 2942-2951.
84. Schramm C., Huber S., Protschka M., Czochra P., Burg J., Schmitt E., Lohse A. W., Galle P. R. and Blessing M. (2004): TGFbeta regulates the CD4+CD25+ T-cell pool and the expression of Foxp3 in vivo. Int. Immunol., 16, 1241-1249.
85. Schubert L. A., Jeffery E., Zhang Y., Ramsdell F. and Ziegler S. F. (2001): Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem., 276, 37672-37679.
86. Shimizu J., Yamazaki S. and Sakaguchi S. (1999): Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J. Immunol., 163, 5211-5218.
87. Shimizu J., Yamazaki S., Takahashi T., Ishida Y. and Sakaguchi S. (2002): Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol., 3, 135-142.
88. Stephens L. A. and Mason D. (2000): CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25- subpopulations. J. Immunol., 165, 3105-3110.
89. Stephens L. A., Mottet C., Mason D. and Powrie F. (2001): Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur. J. Immunol., 31, 1247-1254.
90. Suri-Payer E., Amar A. Z., Thornton A. M. and Shevach E. M. (1998): CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol., 160, 1212-1218.
91. Suri-Payer E. and Cantor H. (2001): Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4(+)CD25(+) T cells. J. Autoimmun., 16, 115-123.
92. Sutmuller R. P., van Duivenvoorde L. M., van Elsas A., Schumacher T. N., Wildenberg M. E., Allison J. P., Toes R. E., Offringa R. and Melief C. J. (2001): Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J. Exp. Med., 194, 823-832.
93. Suvas S., Azkur A. K., Kim B. S., Kumaraguru U. and Rouse B. T. (2004): CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. J. Immunol., 172, 4123-4132.
94. Suvas S., Kumaraguru U., Pack C. D., Lee S. and Rouse B. T. (2003): CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J. Exp. Med., 198, 889-901.
95. Szanya V., Ermann J., Taylor C., Holness C. and Fathman C. G. (2002): The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol., 169, 2461-2465.
96. Takahashi T., Kuniyasu Y., Toda M., Sakaguchi N., Itoh M., Iwata M., Shimizu J. and Sakaguchi S. (1998): Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol., 10, 1969-1980.
97. Takahashi T., Tagami T., Yamazaki S., Uede T., Shimizu J., Sakaguchi N., Mak T. W. and Sakaguchi S. (2000): Immunologic self-tolerance maintained by CD25(+) CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med., 192, 303-310.
98. Tang Q., Henriksen K. J., Bi M., Finger E. B., Szot G., Ye J., Masteller E. L., McDevitt H., Bonyhadi M. and Bluestone J. A. (2004): In vitro-expanded antigen-specific regulatory t cells suppress autoimmune diabetes. J. Exp. Med., 199, 1455-1465.
99. Taylor P. A., Panoskaltsis-Mortari A, Swedin J. M., Lucas P. J., Gress R. E., Levine B. L., June C. H., Serody J. S. and Blazar B. R. (2004): L-Selectin (hi) but not the L-Selectin (lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood, 104, 3804-3812.
100. Thornton A. M., Donovan E. E., Piccirillo C. A. and Shevach E. M. (2004): Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J. Immunol., 172, 6519-6523.
101. Thornton A. M. and Shevach E. M. (1998): CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med., 188, 287-296.
102. Thornton A. M. and Shevach E. M. (2000): Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J. Immunol., 164, 183-190.
103. Thorstenson K. M. and Khoruts A. (2001): Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J. Immunol., 167, 188-195.
104. Tone M., Tone Y., Adams E., Yates S. F., Frewin M. R., Cobbold S. P. and Waldmann H. (2003): Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proc. Natl. Acad. Sci. USA, 100, 15059-15064.
105. van Amelsfort J. M. R., Jacobs K. M. G., Bijlsma J. W., Lafeber F. P. and Taams L. S. (2004): CD4+CD25+ regulatory T cells in rheumatoid arthritis: differences in presence, phenotype and function between peripheral blood and synovial fluid. Arthritis Rheum., 50, 2775-2785.
106. Viglietta V., Baecher-Allan C., Weiner H. L. and Hafler D. A. (2004): Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med., 199, 971-979.
107. Viguier M., Lemaitre F., Verola O., Cho M. S., Gorochov G., Dubertret L., Bachelez H., Kourilsky P. and Ferradini L. (2004): Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J. Immunol., 173, 1444-1453.
108. Walker L. S., Chodos A., Eggena M., Dooms H. and Abbas A. K. (2003): Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J. Exp. Med., 198, 249-258.
109. Walker M. R., Kasprowicz D. J., Gersuk V. H., Benard A., Van Landeghen M., Buckner J. H. and Ziegler S. F. (2003): Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J. Clin. Invest., 112, 1437-1443.
110. Wood K. J., Ushigome H., Karim M., Bushell A., Hori S. and Sakaguchi S. (2003): Regulatory cells in transplantation. Novartis Found Symp., 252, 177-188.
111. Yamazaki S., Iyoda T., Tarbell K., Olson K., Velinzon K., Inaba K. and Steinman R. M. (2003): Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J. Exp. Med., 198, 235-247.
112. Yang Y., Huang C.T., Huang X. and Pardoll D. M. (2004): Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance. Nat. Immunol., 5, 508-515.
113. Zhang X., Koldzic D. N., Izikson L., Reddy J., Nazareno R. F., Sakaguchi S., Kuchroo V. K. and Weiner H. L. (2004): IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int. Immunol., 16, 249-256.
114. Zheng S. G., Gray J. D., Ohtsuka K., Yamagiwa S. and Horwitz D. A. (2002): Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors. J. Immunol., 169, 4183-4189.